Abstract
About 25% of ischemic strokes remain without an established cause. The article describes the characterization of some hereditary and acquired thrombophilias, which play a significant role in genesis of stroke. One of the ways to solve the problem of etiological diagnosis of thrombotic states is to identify the markers of hereditary or acquired pathology and to conduct molecular genetic typing of the hemostasis system factors. Thrombophilia screening is required for all patients with ischemic strokes of unknown etiology.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: PRECARPATHIAN BULLETIN OF THE SHEVCHENKO SCIENTIFIC SOCIETY Pulse
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
